Eli Lilly and Co (LLY :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
LLY FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
Final Glance: Pharmaceuticals companies 8 hrs ago - The Associated Press
-
Midday Glance: Pharmaceuticals companies 13 hrs ago - The Associated Press
-
Early Glance: Pharmaceuticals companies 16 hrs ago - The Associated Press
-
Lilly to take over development of diabetes drug 17 hrs ago - The Associated Press
-
Final Glance: Pharmaceuticals companies 14 Jun 2013 - The Associated Press
-
Midday Glance: Pharmaceuticals companies 14 Jun 2013 - The Associated Press
-
Early Glance: Pharmaceuticals companies 14 Jun 2013 - The Associated Press
-
UPDATE 1-Lilly halts Alzheimer's drug trial due to liver problems 13 Jun 2013 - Reuters
-
Final Glance: Pharmaceuticals companies 13 Jun 2013 - The Associated Press
-
Midday Glance: Pharmaceuticals companies 13 Jun 2013 - The Associated Press
MORE FROM CNBC
-
Cloud Computing: CNBC Explains 11 Jun 2013 - CNBC.com
MORE FROM OUR PARTNERS
-
Successor To Humira? Abbvie And Galapagos Work On It 11 hrs ago - Seeking Alpha
-
Good News For This Small-Cap Biotech: Eli Lilly Wants To Develop Its D... 15 hrs ago - Seeking Alpha
LATEST TRANSCRIPTS
-
Eli Lilly & Co CEO Presents at Goldman Sachs Healthcare Conference (Tr... 12 Jun 2013 - Seeking Alpha
PRESS RELEASES
-
New Data Showed LIVALO?? (pitavastatin) 4 mg had Neutral Effects on Fa... 15 hrs ago - PR Newswire
-
MdBio Foundation Names New Board Members 17 hrs ago - Business Wire
-
Research and Markets: Global Insulin Delivery Devices Market Forecast ... 18 hrs ago - Business Wire
-
Ambrx And Zhejiang Medicine Co. Ltd. Form Collaboration To Develop And... 18 hrs ago - PR Newswire
-
Lilly Diabetes, Kris Freeman Kick off Summer with 9th Annual Diabetes ... 18 hrs ago - PR Newswire
-
Transition Therapeutics Announces Exercise of TT-401 Rights by Lilly 20 hrs ago - PR Newswire
-
Ambrx and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and... 16 Jun 2013 - PR Newswire
-
Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secr... 13 Jun 2013 - PR Newswire
-
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company S... 13 Jun 2013 - PR Newswire
-
Turkey's Non-Small-Cell Lung Cancer Drug Market Projected to Grow at 7... 13 Jun 2013 - PR Newswire
